166 related articles for article (PubMed ID: 38170714)
1. Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study.
Nishiyama S; Uchino S; Sasabuchi Y; Masuyama T; Lefor AK; Sanui M
PLoS One; 2024; 19(1):e0295952. PubMed ID: 38170714
[TBL] [Abstract][Full Text] [Related]
2. Peripherally-active mu-opioid receptor antagonists for constipation in critically ill patients receiving opioids: A case-series and a systematic review and meta-analysis of the literature.
Umbrello M; Venco R; Palandri C; Racagni M; Muttini S
Neurogastroenterol Motil; 2023 Dec; 35(12):e14694. PubMed ID: 37869768
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
Fujita Y; Imai H; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Koizuka S; Saito T; Obayashi K; Kaira K; Minato K
J Palliat Med; 2023 Apr; 26(4):548-553. PubMed ID: 36971576
[No Abstract] [Full Text] [Related]
4. Prevention and management of diarrhea associated with naldemedine among patients receiving opioids: a retrospective cohort study.
Takagi Y; Osawa G; Kato Y; Ikezawa E; Kobayashi C; Aruga E
BMC Gastroenterol; 2020 Jan; 20(1):25. PubMed ID: 32005157
[TBL] [Abstract][Full Text] [Related]
5. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
[TBL] [Abstract][Full Text] [Related]
6. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.
Katakami N; Oda K; Tauchi K; Nakata K; Shinozaki K; Yokota T; Suzuki Y; Narabayashi M; Boku N
J Clin Oncol; 2017 Jun; 35(17):1921-1928. PubMed ID: 28445097
[TBL] [Abstract][Full Text] [Related]
7. Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid-induced constipation: A nationwide retrospective cohort study in Japan.
Abe H; Sumitani M; Matsui H; Inoue R; Fushimi K; Uchida K; Yasunaga H
Pharmacotherapy; 2022 Mar; 42(3):241-249. PubMed ID: 34967450
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.
Nishiba H; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Ito M; Takei S; Matsuura M; Mogi J; Obayashi K; Minato K
Ann Palliat Med; 2023 Jul; 12(4):697-707. PubMed ID: 37081703
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
Esmadi M; Ahmad D; Hewlett A
J Gastrointestin Liver Dis; 2019 Mar; 28(1):41-46. PubMed ID: 30851171
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients.
Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Kaira K; Minato K
Thorac Cancer; 2022 Aug; 13(16):2301-2308. PubMed ID: 35790500
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
Kanbayashi Y; Shimizu M; Ishizuka Y; Sawa S; Yabe K; Uchida M
PLoS One; 2022; 17(12):e0278823. PubMed ID: 36490241
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.
Webster LR; Nalamachu S; Morlion B; Reddy J; Baba Y; Yamada T; Arjona Ferreira JC
Pain; 2018 May; 159(5):987-994. PubMed ID: 29419653
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study.
Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Koizuka S; Saito T; Obayashi K; Kaira K; Minato K
Eur J Gastroenterol Hepatol; 2024 May; 36(5):571-577. PubMed ID: 38477855
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Observational Study of Factors Affecting the Efficacy of Concurrent Prescription of Naldemedine for Opioid-Induced Constipation Caused by Oxycodone Tablets.
Yamada M; Jimaru Y; Torii S; Mitsuba N; Takahashi K
Biol Pharm Bull; 2023; 46(12):1826-1831. PubMed ID: 38044102
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
Kamiya T; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Koizuka S; Saito T; Obayashi K; Kaira K; Minato K
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984494
[No Abstract] [Full Text] [Related]
17. Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics.
Nakatsugawa E; Naito T; Shibata K; Kitajima R; Kawakami J
Fundam Clin Pharmacol; 2024 Jun; 38(3):596-605. PubMed ID: 38192190
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the effect of naldemedine for opioid-induced constipation: a single-institution, retrospective analysis.
Kanbayashi Y; Amaya F; Ueno H; Tabuchi Y; Ishikawa T; Takayama K; Taguchi T
Pharmazie; 2021 Apr; 76(4):175-178. PubMed ID: 33849704
[TBL] [Abstract][Full Text] [Related]
19. Naldemedine (Symproic) for opioid-induced constipation.
Med Lett Drugs Ther; 2017 Dec; 59(1535):196-198. PubMed ID: 29186083
[No Abstract] [Full Text] [Related]
20. Naldemedine-laxative combination: retrospective inpatient study.
Takemura M; Niki K; Miyaguchi S; Ueda M
BMJ Support Palliat Care; 2024 Jan; 13(e3):e816-e819. PubMed ID: 35750467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
